Lästips för ytterligare fördjupning:

  1. Andersen S, Pedersen KM, Bruun NH, Laurberg P 2002 Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease. The Journal of clinical endocrinology and metabolism 87:1068-1072.
  2. Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H et al. (2017). 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease during Pregnancy and the Postpartum. Thyroid, 27, 315–389.
  3. Bartalena L, Baldeschi L, Boboridis K, Eckstein A, Kahaly GJ et al. (2016). On behalf of the European Group on Graves’ Orbitopathy (EUGOGO). The 2016 European Thyroid Association/European Group on Graves’ Orbitopathy Guidelines for the Management of Graves’ Orbitopathy. European Thyroid Journal, 5, 9–26.
  4. Biondi B, Kahaly GJ 2010 Cardiovascular involvement in patients with different causes of hyperthyroidism. Nature reviews Endocrinology 6:431-443.
  5. Biondi B, Wartofsky L 2012 Combination treatment with T4 and T3: toward personalized replacement therapy in hypothyroidism? The Journal of clinical endocrinology and metabolism 97:2256-2271.
  6. Biondi B, Bartalena L, Cooper DS, Hegedüs L, Laurberg P, Kahaly GJ (2015). The 2015 European Thyroid Association Guidelines on diagnosis and treatment of endogenous subclinical hyperthyroidism. European Thyroid Journal, 4(3), 149–63.
  7. Escobar-Morreale HF, Botella-Carretero JI, Morreale de Escobar G 2015 Treatment of hypothyroidism with levothyroxine or a combination of levothyroxine plus L-triiodothyronine. Best practice & research Clinical endocrinology & metabolism 29:57-75.
  8. Grozinsky-Glasberg S, Fraser A, Nahshoni E, Weizman A, Leibovici L 2006 Thyroxine-triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: meta-analysis of randomized controlled trials. The Journal of clinical endocrinology and metabolism 91:2592-2599.
  9. Hallengren B, Törring O. (2011). Sköldkörtelns sjukdomar. Internmedicin: Stenke , Dahlström U, Kechagias S (red). Kapitel 7, Stockholm: Liber. ISBN: 978-91-47-90863-9
  10. Haugen BR, Alexander EK, Bible KC, Doherty GM et al. (2016). 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid, 26,1–133.
  11. Hernandez M et al. Impact of TSH during the first trimester of pregnancy on foetal complications. Usefulness of 2.5 mIU/L cut off values. Clinical Endocrinology ; 88: 728 – 734; 2018
  12. Jonklaas J, Bianco AC, Bauer AJ, Burman KD, Cappola AR et al. (2014). Guidelines for the Treatment of Hypothyroidism. Prepared by the American Thyroid Association Task Force on thyroid hormone replacement. Thyroid, 24, 1670–1751.
  13. Klein Hesselink EN, Klein Hesselink MS, de Bock GH, Gansevoort RT, Bakker SJ, Vredeveld EJ, van der Horst-Schrivers AN, van der Horst IC, Kamphuisen PW, Plukker JT, Links TP, Lefrandt JD 2013 Long-term cardiovascular mortality in patients with differentiated thyroid carcinoma: an observational study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 31:4046-4053.
  14. Lazarus J, Brown RS, Daumerie C, Hubalewska-Dydejczyk A, Negro R, Vaidya B (2014). 2014 European Thyroid Association Guidelines for the management of subclinical hypothyroidism in pregnancy and children. European Thyroid Journal, 3, 76–94.
  15. Nyström E, Berg GEB, Jansson SKG, Tørring O, Valdemarsson S. (2011). Thyroid disease in adults. Berlin-Heidelberg: Springer Verlag. Online e-ISBN:978-3-642-13262-9; ISBN:978-3-64213261-2
  16. Pearce SH, Brabant G, Duntas LH, Monzani F, Peeters RP et al. (2013). “2013 ETA Guideline: Management of Subclinical Hypothyroidism.” Eur Thyroid J 2(4): 215-228.
  17. Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P et al. (2016). American Thyroid Association Guidelines for Diagnosis and Management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 26, 1343–1421
  18. Rotondi M, Chiovata L, Pacini F, Bartalena L, Vitti P. Management of subclinical hypothyroidism during pregnancy. A comment from the Italian Thyroid Association to the 2015 American Thyroid Association guidelines. The Italian Way. The Thyroid; 28/5 May pp 551-555, 2018
  19. Sjöberg S, Lantz M. (2015) Sköldkörtelns sjukdomar. I Sjöberg S, Mattson C (red): Klinisk endokrinologi, kapitel 3. Studentlitteratur AB, Stockholm.ISBN 9789144088129
  20. Tyreoideasjukdomar i samband med graviditet. (2017). Riktlinjer från SEF och SFOG. http://endokrinologforeningen.se/documents/SFOGtyreoideasjukdom_i_samband_med_graviditet._riktlinjer_2017-11-09_klart.pdf
  21. Valdemarsson S. (2016). Sjukdomar i tyreoidea. I Hedin K, Löndahl M. (red): Allmänläkarpraktikan – Diabetes och andra endokrina sjukdomar, kapitel 3. Studentlitteratur AB, Stockholm. ISBN 9789144085760
  22. Wiersinga WM (2017). Therapy of endocrine disease: T4 + T3 combination therapy: is there a true effect? European journal of endocrinology / European Federation of Endocrine Societies 177:R287-r296.
  23. Wiersinga WM, Duntas L, Fadeyev V, Nygaard B, Vanderpump MP (2012). 2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism. European thyroid journal 1:55-71.